EMD-45971

Single-particle
2.8 Å
EMD-45971
3D View Gallery
Deposition: 30/07/2024
Map released: 21/01/2026
Last modified: 21/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-45971
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9cwq summary report (pdf.gz) Map and 9cwq FULL report (pdf.gz)
EMICSS annotations (xml)

Local refinement of the SARS-CoV-2 BA.2.86 NTD

EMD-45971

Single-particle
2.8 Å
EMD-45971
3D View Gallery
Deposition: 30/07/2024
Map released: 21/01/2026
Last modified: 21/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Sarbecovirus sp., Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 BA.2.86 NTD
Fitted models: 9cwq

Deposition Authors: Lee J, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
The computationally designed TRI2-2 miniprotein inhibitor protects against multiple SARS-CoV-2 Omicron variants.
Lee J, Case JB, Park YJ, Ravichandran R, Asarnow D, Tortorici MA, Brown JT, Sanapala S, Carter L, Baker D, Diamond MS, Veesler D
(2026) Commun Biol
PUBMED: 41519898
DOI: doi:10.1038/s42003-025-09499-2
ISSN: 2399-3642